Higher local Ebola incidence causes lower child vaccination rates

The impact of the Ebola epidemic on the child vaccination rate.

Boehringer, Lilly secure EC approval for Jardiance to treat CKD

The trial assessed the effect of empagliflozin on kidney disease progression and cardiovascular mortality risk in 6,609 participants. Credit: Marko Aliaksandr / Shutterstock.com. Boehringer Ingelheim

July 26, 2023

Outcomes OK With Transplant of Previously Dialyzed Kidneys

Transplant recipients with kidneys from donors who underwent dialysis had significantly higher risk for delayed graft function (DGF) but no long-term differences in graft failure,

May 24, 2024

Roivant makes another deal, selling Dermavant to Organon for up to $1.2B

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

September 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.